ADVFN Logo
Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.

LTRN Lantern Pharma Inc

8.95
-0.83 (-8.49%)
After Hours
Last Updated: 18:04:11
Delayed by 15 minutes
Company Name Stock Ticker Symbol Market Type
Lantern Pharma Inc LTRN NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
-0.83 -8.49% 8.95 18:04:11
Open Price Low Price High Price Close Price Prev Close
9.64 8.50 10.0575 8.80 9.78
more quote information »

Recent News

Date Time Source Heading
3/18/202416:02BWLantern Pharma Reports Fourth Quarter & Fiscal Year 2023..
3/18/202407:12IHMARKETNEWSAnticipation Builds on Wall Street for Federal Reserve’s..
3/15/202408:00BWLantern Pharma Announces Initial Patients Dosed in..
3/11/202407:30BWLantern Pharma to Report Fourth Quarter and Fiscal Year 2023..
3/05/202408:01BWLantern To Participate in H.C Wainwright & Co.’s (HCW) 1st..
3/04/202408:01BWLantern Pharma's A.I. Platform, RADR®, Surpasses 60 Billion..
2/29/202421:54EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2/15/202408:01BWLantern Pharma Advances Unique ADC (Antibody Drug Conjugate)..
1/19/202416:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
1/17/202407:30BWStarlight Therapeutics, a Subsidiary of Lantern Pharma..
12/29/202316:05EDGAR2Form 8-K - Current report
12/01/202306:02EDGAR2Form SC 13D/A - General statement of acquisition of..
12/01/202306:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11/30/202308:00BWFDA Grants Lantern Pharma Orphan Drug Designation for Drug..
11/24/202316:05EDGAR2Form 8-K - Current report
11/08/202316:05EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
11/08/202316:05EDGAR2Form 8-K - Current report
11/08/202316:01BWLantern Pharma Reports Third Quarter 2023 Financial Results..
11/01/202308:00BWLantern Pharma to Report Third Quarter 2023 Operating &..
10/20/202317:25EDGAR2Form 8-K - Current report
10/10/202308:00BWLantern Pharma to Present at the ThinkEquity Conference on..
10/03/202308:00BWLantern Pharma Announces Publication in Clinical Cancer..
9/25/202308:30BWLantern Pharma Announces First Patient Dosed in the Phase 1..
9/18/202309:00BWLantern Pharma Receives IND Clearance from FDA Enabling..
8/31/202308:00BWLantern Pharma to Present Data Highlighting the Anti-Tumor..
8/28/202308:00BWLantern Pharma Expands AI Capabilities of RADR® Platform to..
8/14/202308:30BWLantern Pharma Receives Notice of US Patent Allowance for..
8/09/202316:05EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
8/09/202316:05EDGAR2Form 8-K - Current report
8/09/202316:01BWLantern Pharma Reports Second Quarter 2023 Financial Results..
8/02/202308:00BWLantern Pharma to Report Second Quarter 2023 Operating &..
7/17/202308:00BWLantern Pharma to Participate and Present at Multiple..
6/26/202308:30BWOncotarget Publishes New Data by Lantern Pharma, an AI..
6/12/202308:30BWLantern Pharma Receives FDA Clearance of IND Application for..
6/08/202309:00BWLantern Pharma Leverages AI Platform, RADR®, to Develop..
5/17/202308:00BWLantern Pharma to Present at the Lytham Partners Spring 2023..
5/09/202316:01BWLantern Pharma Reports First Quarter 2023 Financial Results..
5/03/202309:00PRNUSLantern Pharma Selects REPROCELL USA to Provide Support for..
5/02/202316:01BWLantern Pharma to Report First Quarter 2023 Operating &..
5/02/202307:30BWLantern Pharma Develops Top-Ranked AI Algorithms to Predict..
4/13/202307:30BWLantern Pharma Receives Notice of Allowance for Composition..

Your Recent History

Delayed Upgrade Clock